IDH3A and central nervous system cancer: The 2016 WHO classification of brain tumours puts more emphasis on the genetic and molecular subtyping of gliomas by stratifying them according to the isocitrate-dehydrogenase-(IDH) and 1p/19q mutation status or co-deletion, respectively [26].